Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
20
Number of overlapping holdings
31.7%
% of XLV's 64 holdings also in GDOC
44.4%
% of GDOC's 48 holdings also in XLV
Overlap by Weight
Sector Drift (XLV minus GDOC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in GDOC |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 11.2% | 10.4% | 10.4% |
|
DANAHER CORP | 3.0% | 3.6% | 3.0% |
|
AMGEN INC | 2.8% | 3.5% | 2.8% |
|
INTUITIVE SURGICAL INC | 2.5% | 4.6% | 2.5% |
|
BRISTOL-MYERS SQUIBB CO | 1.9% | 2.7% | 1.9% |
Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to GDOC
|
UNITEDHEALTH GROUP INC | 9.0% |
|
JOHNSON & JOHNSON | 6.9% |
|
MERCK & CO. INC. | 6.2% |
|
ABBVIE INC | 5.7% |
|
THERMO FISHER SCIENTIFIC INC | 4.1% |
|
ABBOTT LABORATORIES | 3.6% |
|
PFIZER INC | 2.9% |
|
ELEVANCE HEALTH INC | 2.4% |
|
STRYKER CORP | 2.1% |
 |
MEDTRONIC PLC | 2.1% |
XLV Underweight Relative to GDOC
 |
ASTRAZENECA PLC | -5.2% |
 |
NOVO NORDISK A/S-B | -5.1% |
|
BOSTON SCIENTIFIC CORP | -4.0% |
|
COOPER COS INC/THE | -3.3% |
|
BIOMARIN PHARMACEUTICAL INC | -3.2% |
|
ZIMMER HOLDINGS INC | -2.9% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -2.8% |
 |
CSL LIMITED | -2.8% |
|
NEUROCRINE BIOSCIENCES INC | -2.5% |
|
INSULET CORP | -2.5% |